Mylan will start selling a cheaper version of its EpiPen after absorbing waves of criticism over a list price for the emergency allergy treatment that has grown to $608 for a two-pack, making it unaffordable for many patients. The drugmaker says it will launch in several weeks a generic EpiPen version that is identical to … Continue reading →